Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel
Wael Al Mahmeed, Nader Lessan(Imperial College London Diabetes Centre), Yajnavalka Banerjee(University of Dundee), Ali A. Rizvi(Emory University), Su‐Yen Goh(Singapore General Hospital), Khalid Al‐Rasadi(Sultan Qaboos University Hospital), Raul D. Santos(Hospital Israelita Albert Einstein), Massimo Galia(University of Palermo), Manfredi Rizzo(University of Palermo), Peter P. Tóth(University of Debrecen), Νικόλαος Παπάνας(Democritus University of Thrace), Francesco Cosentino(Linköping University), Anca Pantea Stoian(University of Bucharest), Péter Kempler(Semmelweis University), Antonio Ceriello(MultiMedica)
Cited by 48
Related Papers
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
|European Heart Journal|2013|1.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
|Arteriosclerosis Thrombosis and Vascular Biology|2004|1.4k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716
Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC)
|Nutrition Metabolism and Cardiovascular Diseases|2015|691